DEERFIELD MANAGEMENT COMPANY, L.P.

Position in PMVP — PMV Pharmaceuticals, Inc.

CIK 1009258 NEW YORK, NY

Position in PMVP

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$10,899

-$88 QoQ

Shares Held

8,790

0.0% QoQ

Ownership

0.016%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

DEERFIELD MANAGEMENT COMPANY, L.P. holds $5,090,522,306 across 44 Biotechnology names. PMVP ranks #44 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NUVL	Nuvalent, Inc.	17,248,450	$1,767,103,702
2	COGT	Cogent Biosciences, Inc.	9,043,903	$348,099,826
3	PRAX	Praxis Precision Medicines, Inc.	963,351	$310,382,058
4	RVMD	Revolution Medicines, Inc.	2,297,000	$223,383,250
5	CELC	Celcuity Inc.	1,714,000	$195,635,960
6	LRMR	Larimar Therapeutics, Inc.	35,606,974	$160,231,383
7	VERA	Vera Therapeutics, Inc.	3,722,100	$149,740,083
8	IONS	Ionis Pharmaceuticals Inc	1,979,669	$148,653,345

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$10,899	8,790	0.0%	Shares	Defined	2026-05-15
2025-12-31	$10,987	8,790	0.0%	Shares	Defined	2026-02-17
2025-09-30	$12,306	8,790	0.0%	Shares	Defined	2025-11-14
2025-06-30	$9,317	8,790	+1770.2%	Shares	Defined	2025-08-14
2022-03-31	$9,785	470	-99.9%	Shares	Defined	2022-05-16
2021-12-31	$12,058,200	522,000	-35.1%	Shares	Defined	2022-02-14
2021-09-30	$23,959,200	804,000	0.0%	Shares	Defined	2021-11-15
2021-06-30	$27,464,640	804,000	+89.8%	Shares	Defined	2021-08-16
2021-03-31	$13,934,835	423,680	+126.3%	Shares	Defined	2021-05-17
2020-12-31	$11,514,179	187,192	+274.4%	Shares	Defined	2021-02-16
2020-09-30	$1,775,000	50,000	—	Shares	Defined	2020-12-30
No filing history on record for this holder in this stock.